Research
Bristol Myers reports patient death in autoimmune CAR-T trial
Endpoints identified the trial as an MS CAR-T study after reporting a patient death.

The original reports on this story are listed below.
Research
Endpoints identified the trial as an MS CAR-T study after reporting a patient death.

The original reports on this story are listed below.

Cancer
In a phase 3 trial, adding intismeran to pembrolizumab reduced recurrence or death risk by 42% compared with pembrolizumab alone.

Infectious disease
Kenya has reported nine cases and Nigeria one, as officials investigate whether the first patients crossed paths at Uganda’s Entebbe airport.

Health policy
Means resigned from his White House role, with a source telling NBC News that delays to his ultraprocessed-food policy goal were a final straw.
This Week in Medicine
The most important medical news of the week, summarized for you and easy to read. Every Sunday, free.
Free. No spam. Unsubscribe anytime.